KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Current Taxes (2016 - 2025)

Merck (MRK) has disclosed Current Taxes for 17 consecutive years, with $4.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Current Taxes rose 20.75% to $4.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.7 billion, a 20.75% increase, with the full-year FY2025 number at $4.7 billion, up 20.75% from a year prior.
  • Current Taxes was $4.7 billion for Q4 2025 at Merck, down from $4.8 billion in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $5.2 billion in Q1 2025 to a low of $954.0 million in Q3 2021.
  • A 5-year average of $2.6 billion and a median of $2.0 billion in 2022 define the central range for Current Taxes.
  • Peak YoY movement for Current Taxes: dropped 23.36% in 2021, then skyrocketed 118.58% in 2024.
  • Merck's Current Taxes stood at $1.2 billion in 2021, then skyrocketed by 62.25% to $2.0 billion in 2022, then surged by 33.38% to $2.6 billion in 2023, then soared by 47.75% to $3.9 billion in 2024, then increased by 20.75% to $4.7 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Current Taxes are $4.7 billion (Q4 2025), $4.8 billion (Q3 2025), and $4.2 billion (Q2 2025).